These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 387810)

  • 21. Phenotypic variation of clinical Serratia marcescens isolates repeatedly recovered from individual patients.
    Traub WH; Eiden A; Leonhard B; Bauer D
    Zentralbl Bakteriol; 1996 Jun; 284(1):124-35. PubMed ID: 8837376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Numerical analysis of SDS-PAGE protein patterns of Serratia marcescens: a comparison with other typing methods.
    Holmes B; Costas M; Sloss LL
    Epidemiol Infect; 1990 Aug; 105(1):107-17. PubMed ID: 2200696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriocin (marcescin) typing of clinically isolated Serratia marcescens.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):33-43. PubMed ID: 7015560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):982-5. PubMed ID: 4555641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Typing of nosocomial strains of Serratia marcescens: comparison of restriction enzyme cleaved genomic DNA fragment (PFGE) analysis with bacteriocin typing, biochemical profiles and serotyping.
    Traub WH; Eiden A; Leonhard B; Bauer D
    Zentralbl Bakteriol; 1996 Jun; 284(1):93-106. PubMed ID: 8837373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriocin typing and biotyping of clinical isolates of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol; 1991 Oct; 275(4):474-86. PubMed ID: 1755921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated analysis of 35-S-methionine labeled proteins by SDS-PAGE as a typing method in a suspected cluster of Serratia marcescens.
    Altwegg M; Lüthy-Hottenstein J; Grehn M; von Graevenitz A
    Zentralbl Bakteriol; 1989 Sep; 271(3):372-80. PubMed ID: 2679619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens.
    Alonso R; Aucken HM; Perez-Diaz JC; Cookson BD; Baquero F; Pitt TL
    Epidemiol Infect; 1993 Aug; 111(1):99-107. PubMed ID: 8102336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotyping of Serratia marcescens: identification of a new O-antigen (O24).
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):485-8. PubMed ID: 2413654
    [No Abstract]   [Full Text] [Related]  

  • 30. [O-serotypes, biochemical properties and antimicrobial susceptibility of Serratia marcescens isolates from clinical specimens].
    Marumo K; Aoki Y; Takeuchi T
    Rinsho Byori; 1987 May; 35(5):555-60. PubMed ID: 2441093
    [No Abstract]   [Full Text] [Related]  

  • 31. Passive protection of NMRI mice against Serratia marcescens: comparative efficacy of commercial human IgG immunoglobulin preparations and rabbit anti-O, -H, -K, -life cell and -protease immune sera.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):480-8. PubMed ID: 6202079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nosocomial Serratia marcescens individualized by five typing methods in a regional hospital.
    Larose P; Picard B; Thibault M; Grimont F; Goullet P
    J Hosp Infect; 1990 Feb; 15(2):167-72. PubMed ID: 1969439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic variations of bacteriocin susceptibility, O-antigen determinants, and serum susceptibility among isolates of a multiple-drug-resistant, nosocomially significant strain of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol Orig A; 1978 Jan; 240(1):57-75. PubMed ID: 76383
    [No Abstract]   [Full Text] [Related]  

  • 34. Serotyping of Serratia marcescens: detection of two new O-antigens (O25 and O26).
    Traub WH
    Zentralbl Bakteriol; 1991 Oct; 275(4):495-9. PubMed ID: 1721816
    [No Abstract]   [Full Text] [Related]  

  • 35. [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].
    Minck R; Le Minor S; Pigache F; Dammron A; Reeb E; Kohen M; Le Faou A
    Pathol Biol (Paris); 1980 Oct; 28(8):501-7. PubMed ID: 7001322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved O-serotyping method for Serratia marcescens.
    Gaston MA; Pitt TL
    J Clin Microbiol; 1989 Dec; 27(12):2702-5. PubMed ID: 2480362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Serratia marcescens isolates from subgingival biofilm, extraoral infections and environment by prodigiosin production, serotyping, and genotyping.
    Barbosa FC; Irino K; Carbonell GV; Mayer MP
    Oral Microbiol Immunol; 2006 Feb; 21(1):53-60. PubMed ID: 16390342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of agglutinating antisera specific for the flagellar antigens of Pseudomonas aeruginosa.
    Pitt TL
    J Med Microbiol; 1981 Aug; 14(3):251-60. PubMed ID: 6790705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continued epidemiological surveillance of Serratia marcescens infections by bacteriocin typing, with particular reference to strains isolated at Erlangen.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1974; 229(3):372-82. PubMed ID: 4155886
    [No Abstract]   [Full Text] [Related]  

  • 40. Virulence of nosocomial isolates of Serratia marcescens for NMRI mice: correlation with O-antigens O6 and O14.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):360-9. PubMed ID: 6182709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.